Equities

Patterson Companies Inc

Patterson Companies Inc

Actions
  • Price (USD)29.21
  • Today's Change-0.57 / -1.91%
  • Shares traded733.84k
  • 1 Year change-8.69%
  • Beta1.5112
Data delayed at least 15 minutes, as of Dec 03 2021 21:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Patterson Companies, Inc. is a specialty distributor serving the United States and Canadian dental supply markets and the United States, Canadian and the United Kingdom animal health supply markets. The Company's segments include Dental, Animal Health and Corporate. The Dental segment provides a range of consumable dental products, equipment and software, turnkey digital solutions and services to dentists, dental laboratories, institutions, and other healthcare professionals throughout North America. This segment offers consumable products including infection control, restorative materials, and instruments. The Animal Health segment distributes animal health products, services, and technologies to both the production-animal and companion-pet markets in North America and the United Kingdom. Products it distributes include pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, consumable supplies, equipment and software.

  • Revenue in USD (TTM)6.38bn
  • Net income in USD159.84m
  • Incorporated1992
  • Employees7.80k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Lantheus Holdings Inc389.80m-34.48m1.81bn595.00--3.62450.924.63-0.5112-0.51125.787.380.45136.126.88655,122.70-3.996.05-4.406.9643.8047.97-8.847.432.18-4.080.26180.00-2.282.95-142.55---1.05--
Glaukos Corp294.01m-38.37m1.95bn653.00--3.24--6.63-0.8477-0.84776.3112.830.28563.508.63450,237.40-3.73-6.01-3.94-6.6076.4178.99-13.05-12.377.60-3.740.3697---5.0725.69-880.26---15.27--
Outset Medical Inc91.70m-122.75m2.18bn313.00--5.31--23.75-2.77-2.772.068.710.20053.776.95292,961.70-26.83---29.21--5.13---133.86--9.64-90.750.0677--231.18--7.18------
Fulgent Genetics Inc1.04bn569.33m2.49bn429.004.342.404.342.4119.2419.2434.6534.761.43--9.722,414,664.0077.8233.2591.1738.1280.1974.6654.5439.63----0.01980.001,196.46113.1952,243.55--75.67--
Adapthealth Corp2.12bn-42.36m2.51bn8.70k--1.2617.591.19-1.60-1.6018.0715.060.627622.838.55243,119.00-1.87---2.13--21.01---2.98--1.441.580.5278--102.15---657.38------
NuVasive, Inc.1.13bn-25.66m2.54bn2.70k--3.0821.012.25-0.4976-0.497621.8515.950.47121.055.58418,044.40-1.071.55-1.361.8171.3572.62-2.272.572.351.770.51760.00-10.065.31-156.95--0.3312--
Axonics Inc161.94m-76.25m2.57bn416.00--5.24--15.87-1.83-1.833.9010.590.35631.047.31389,274.00-16.78---18.10--63.27---47.09--9.36-8.100.0002--707.06--31.30------
Cytek Biosciences Inc-100.00bn-100.00bn2.61bn462.00--6.47----------3.01------------------------13.74--0.00--60.39--119.11------
Integer Holdings Corp1.18bn88.45m2.70bn7.50k30.732.0315.952.292.662.6635.4340.350.49075.555.50156,936.403.692.293.942.4727.8929.447.515.191.884.540.32130.00-14.686.05-15.30--2.89--
Haemonetics Corporation933.83m31.24m2.74bn2.71k88.683.9222.382.940.60490.604918.2613.680.58011.596.60344,839.401.943.922.414.9146.6146.023.355.591.315.840.52780.00-11.94-0.8593.85---18.40--
Patterson Companies, Inc.6.38bn159.84m2.90bn7.80k18.212.8712.070.4541.641.6465.2210.372.246.4013.10817,576.705.58-0.34759.28-0.49220.1121.732.49-0.19960.8125--0.3844--7.691.88126.51-3.43-20.132.93
Owens & Minor, Inc.9.68bn230.36m3.04bn6.30k12.813.439.430.3143.143.14131.7911.762.816.2113.361,536,509.006.70-1.1011.44-1.8016.2212.652.38-0.39480.62028.240.5196---7.93-2.80489.98-2.9910.08-60.27
AtriCure Inc.258.84m45.38m3.12bn750.0073.376.3956.5812.060.92590.92595.8210.630.3921.808.78345,114.706.87-8.447.43-9.3574.6772.6717.53-17.002.9130.380.1215---10.529.74-36.83---17.12--
Nevro Corp393.88m-108.36m3.19bn843.00--9.98--8.09-3.12-3.1211.359.150.57891.355.54467,231.30-15.92-12.91-20.71-15.3269.8069.17-27.51-17.965.97-2.920.318---7.2339.0719.89--3.77--
Merit Medical Systems, Inc.1.05bn43.22m3.54bn5.99k82.293.5027.263.360.76280.762818.5517.950.63632.817.20176,033.202.611.362.971.5244.3643.604.102.171.2013.450.21570.00-3.1112.20-280.57---1.41--
Conmed Corp989.49m62.24m3.95bn3.40k68.865.2329.604.001.961.9631.4525.850.56592.155.96291,027.303.561.603.971.7955.4154.666.292.751.172.510.486496.80-9.703.70-66.75-20.78-2.810.00
Data as of Dec 03 2021. Currency figures normalised to Patterson Companies Inc's reporting currency: US Dollar USD

Institutional shareholders

47.10%Per cent of shares held by top holders
HolderShares% Held
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 202111.62m11.94%
BlackRock Fund Advisorsas of 30 Sep 20218.96m9.21%
The Vanguard Group, Inc.as of 30 Sep 20218.40m8.64%
Dimensional Fund Advisors LPas of 30 Sep 20214.07m4.19%
SSgA Funds Management, Inc.as of 30 Sep 20212.71m2.79%
Victory Capital Management, Inc. (Investment Management)as of 30 Sep 20212.70m2.77%
American Century Investment Management, Inc.as of 30 Sep 20212.18m2.24%
River Road Asset Management LLCas of 30 Sep 20211.88m1.93%
Allspring Global Investments LLCas of 30 Sep 20211.69m1.74%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20211.62m1.66%
More ▼
Data from 30 Sep 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.